Neoventa
This is the international version of the site. Change region...

News

2010-06-14

Press release: New Nanotechnology opens up new possibilities in perinatal care that may significantly improve outcomes during childbirth.

Mölndal 2010-06-14

Researchers at the Ångström Laboratory in Uppsala, Sweden have discovered a new method to manufacture nanomaterial sensors so that it becomes possible to for example measure different components of body liquids, i.e. blood or amniotic fluid.

Nanexa AB, the company that now owns this technology, has recently signed an exclusive agreement with Neoventa Medical AB to develop this very promising technology with in the perinatal care area. In the first application Neoventa and Nanexa will develop a sensor that measures lactate during labour and delivery. Lactate is an indicator for oxygen depletion of the fetus.

Read the full press release here (PDF)

Back
© 2009 Neoventa Medical AB. All rights reserved. About Neoventa and this website.
Content on this site applies to Europe, Middle East, Asia and Africa. For USA site visitors, please click here